Linear IgA bullous dermatosis secondary to drugs: a real-world pharmacovigilance study of the FDA adverse event reporting system by Yixuan Yang, Hanzhang Xie, Shuhan Liu, Ying Jia, Bingnan Cui, Zhanshuo Xiao

Subjects: “…linear IgA bullous dermatosis…”
Get full text

A histopathological overlap of linear IgA bullous dermatosis and vasculitis by Tharani Murali, MHS, Le Wen Chiu, MD, Nicole L. Bolick, MD, MPH, Emily Altman, MD, Julie Harrington, MD, Charles M. Phillips, MD

Subjects: “…linear IgA bullous dermatosis…”
Get full text

Linear IgA bullous dermatosis–a fifty year experience of Warsaw Center of bullous diseases by Cezary Kowalewski, Katarzyna Wozniak

Subjects: “…linear IgA bullous dermatosis…”
Get full text